What is Sales and Marketing Strategy of Viatris Company?

Viatris Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What is Viatris's Sales and Marketing Strategy?

Viatris, a global healthcare company established in November 2020, has quickly carved out a unique position with a sales and marketing strategy centered on making medicines accessible to everyone. The company was built on the idea of bridging the gap between generic and branded medications, boasting a substantial portfolio of around 1,400 molecules across numerous therapeutic areas and dosage forms. Its operations span over 165 countries, reflecting a commitment to providing sustainable healthcare solutions and improving lives globally.

The company's strategic direction has involved significant portfolio adjustments, including notable divestitures in 2024. Viatris completed the sale of its over-the-counter business in July 2024 and its women's healthcare business in March 2024, while retaining rights to key products in specific regions. This streamlining, coupled with a focus on complex generics and innovative products, signals a shift towards a more concentrated, high-growth business model. Despite reporting total revenues of $14.7 billion in 2024 and $3.3 billion for Q1 2025 (a 2% decrease on a divestiture-adjusted operational basis), Viatris anticipates new product revenues between $450 million and $550 million in 2025, highlighting its drive for future growth through innovation and targeted product introductions.

Understanding how Viatris distributes its extensive product range through various sales channels is crucial to grasping its overall business strategy. The company employs a diverse array of marketing tactics designed to build brand awareness and stimulate sales, aiming to establish a distinct brand positioning within a highly competitive pharmaceutical landscape. Key marketing initiatives are central to reinforcing its core mission and achieving its commercial objectives, including strategies for emerging markets sales and its approach to pharmaceutical sales force management.

Viatris's sales strategy is characterized by a multi-channel distribution network, ensuring broad market penetration for its diverse product portfolio. The company's pharmaceutical marketing efforts focus on educating healthcare professionals and patients about the benefits and accessibility of its treatments. Viatris's sales approach emphasizes building strong relationships with healthcare providers and distributors, facilitating efficient market access.

The Viatris marketing strategy is multifaceted, incorporating digital marketing for healthcare, customer engagement in sales, and patient advocacy marketing. Viatris's competitive analysis of marketing strategies informs its campaigns, particularly for biosimilars and prescription medications. The company's product launch marketing plan is designed for maximum impact, supported by robust Viatris sales training programs.

Viatris's brand positioning in the market is built on its commitment to universal access and quality. The company's sales performance metrics are closely monitored to ensure effectiveness. Viatris's digital marketing strategy for healthcare aims to reach a wider audience and enhance patient engagement. The Viatris sales and marketing plan for generic drugs is a cornerstone of its accessibility mission.

Exploring how Viatris markets its products reveals a strategic focus on both traditional and innovative methods. Viatris's marketing campaigns for biosimilars are particularly noteworthy, showcasing its commitment to advanced therapies. The Viatris sales tactics for prescription medications are tailored to specific therapeutic areas, ensuring targeted outreach.

Viatris's strategy for emerging markets sales is crucial for its global expansion. The Viatris approach to pharmaceutical sales force development ensures a knowledgeable and effective sales team. Viatris's customer engagement in sales is paramount for long-term success.

The Viatris product launch marketing plan is meticulously crafted to ensure successful market entry. Viatris sales training programs are designed to equip its sales force with the necessary skills and knowledge. Viatris brand positioning in the market differentiates it from competitors.

Viatris strategies for patient advocacy marketing highlight its patient-centric approach. Viatris sales performance metrics provide insights into the effectiveness of its sales efforts. Viatris digital marketing strategy for healthcare is continuously evolving to meet market demands.

The Viatris sales and marketing plan for generic drugs is a testament to its core mission. What are Viatris's key marketing initiatives? These often involve collaborations and educational programs. Viatris strategy for emerging markets sales is adapted to local healthcare needs and regulations.

Viatris's approach to pharmaceutical sales force management focuses on continuous development and performance. Viatris marketing campaigns for biosimilars aim to increase awareness and adoption. Viatris sales tactics for prescription medications are data-driven and responsive to market dynamics.

Viatris digital marketing strategy for healthcare leverages various online platforms to connect with stakeholders. Viatris customer engagement in sales is built on trust and value. Viatris competitive analysis of marketing strategies helps it stay ahead in the dynamic pharmaceutical sector.

The Viatris product launch marketing plan is a critical component of its growth strategy. Viatris sales training programs are comprehensive, covering product knowledge and selling skills. Viatris brand positioning in the market emphasizes reliability and affordability.

Viatris strategies for patient advocacy marketing empower patients and support their healthcare journeys. Viatris sales performance metrics are used to refine strategies and improve outcomes. The Viatris BCG Matrix can be a useful tool in understanding its product portfolio's strategic positioning.

Viatris employs a multifaceted sales strategy that leverages both direct engagement and a broad distribution network to ensure its diverse pharmaceutical portfolio reaches patients globally. The company's primary sales approach involves dedicated sales teams who directly interact with healthcare professionals, including physicians, pharmacists, and hospital administrators. This direct channel is fundamental to promoting its range of branded, generic, and biosimilar products across various therapeutic areas, underscoring a key aspect of the Viatris sales approach.

The company's extensive global commercial footprint is a significant asset, enabling it to reach over 1 billion patients annually in more than 165 countries and territories. This expansive reach is supported by a robust distribution network that includes wholesale distributors and partner retailers. Viatris also maintains a presence in diverse healthcare settings, from e-commerce platforms and retail pharmacies to private hospitals, reflecting an omnichannel integration designed for maximum accessibility.

Viatris's business strategy includes a focus on expanding its presence in key growth regions. In 2024, the company continued to bolster its portfolio in Emerging Markets and the JANZ region, with notable growth observed in Greater China. This expansion is driven by localized commercial strategies tailored to the specific needs and dynamics of these markets, demonstrating Viatris's commitment to market penetration in diverse geographies. The company also actively pursues strategic partnerships to broaden its market reach and introduce innovative treatments.

Direct Sales Force Engagement

Viatris utilizes direct sales teams to engage healthcare professionals, promoting its diverse product portfolio. This direct interaction is vital for building relationships and educating prescribers on the benefits of its branded, generic, and biosimilar offerings.

Omnichannel Distribution Network

The company's distribution strategy encompasses wholesale distributors, retail pharmacies, and e-commerce platforms. This omnichannel approach ensures medicines are readily available to patients across various access points, aligning with the Viatris business strategy of broad accessibility.

Emerging Markets and Strategic Partnerships

Viatris prioritizes expansion in Emerging Markets and regions like JANZ, supported by localized commercial efforts. Strategic collaborations, such as the February 2024 R&D agreement with Idorsia, enhance market reach and introduce innovative assets, reflecting Viatris's strategy for emerging markets sales.

Global Healthcare Gateway Infrastructure

The company leverages its 'Global Healthcare Gateway' infrastructure to facilitate patient access to innovative treatments worldwide. This infrastructure is instrumental in managing the complexities of global pharmaceutical distribution and market access, a core component of the Viatris sales strategy.

Key Sales and Marketing Initiatives

Viatris's sales and marketing plan for generic drugs and biosimilars focuses on demonstrating value and ensuring broad patient access. The company's marketing campaigns for biosimilars aim to educate healthcare providers and patients about their efficacy and affordability.

• Direct engagement with physicians and pharmacists.
• Extensive global distribution network.
• Focus on emerging markets and strategic partnerships.
• Leveraging digital channels for broader reach.
• Tailored marketing campaigns for biosimilars and generics.

Viatris SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Viatris employs a comprehensive marketing strategy that blends digital innovation with established traditional methods to effectively reach healthcare professionals and patients. This dual approach is central to its mission of ensuring global access to medicines, focusing on building awareness, providing crucial education, and ultimately driving sales. The company's Viatris sales strategy is deeply intertwined with its commitment to medical education and accessibility.

In the digital sphere, Viatris actively develops and utilizes online platforms to disseminate medical information and support healthcare professionals. An example of this is the NCD Academy, a free online resource that saw significant growth in 2024, adding over 6,000 users and reaching more than 30,000 accounts, impacting an estimated 115 million patients cumulatively. This demonstrates a strong Viatris digital marketing strategy for healthcare. Furthermore, the company leverages popular messaging applications for direct communication; in Malaysia, Viatris launched WhatsApp Connect WACR in 2024 to share medical information with nearly 2,000 healthcare professionals. Digital tools like the SCORE_VN application, developed in partnership with the Vietnam National Heart Association, also play a vital role in educating healthcare professionals, recording over 221,000 visits by August 2024.

Beyond its digital initiatives, Viatris maintains a strong presence in traditional marketing channels. This includes active participation in major medical congresses and the organization of educational programs tailored for healthcare professionals. The company also fosters strategic partnerships with patient organizations to enhance disease awareness and expand access to treatments. A notable example is Viatris's support for the Young Survival Coalition, where initiatives like the Congressional Women's Softball Game helped raise over $3.7 million by 2024 to aid young adults affected by cancer. These efforts underscore Viatris's commitment to patient advocacy marketing. The company also engages in disease awareness campaigns and operates patient assistance programs, offering certain medicines at no cost to patients facing financial hardship. Viatris’s marketing mix is continuously refined to concentrate on its core strengths and develop capabilities to address unmet medical needs, particularly for complex generics and novel products. While specific details on paid advertising or influencer collaborations are less publicized, the overarching focus remains on scientific and medical education, regulatory engagement, and direct communication with healthcare providers, a necessity in the highly regulated pharmaceutical sector. This approach shapes the Viatris sales approach and its Viatris market penetration efforts.

Digital Education Platforms

Viatris utilizes online educational resources like the NCD Academy to support healthcare professionals globally. These platforms are crucial for disseminating medical knowledge and improving patient care outcomes.

Messaging Application Engagement

The company employs messaging applications, such as WhatsApp Connect WACR in Malaysia, for direct and efficient communication of medical information to healthcare providers. This ensures timely updates and engagement.

Healthcare Professional Support Tools

Digital tools like the SCORE_VN application are developed in collaboration with medical associations to provide ongoing education and support for healthcare professionals. These tools enhance their capabilities and knowledge.

Medical Congress Participation

Viatris actively participates in medical congresses, providing a platform to showcase research, engage with peers, and discuss advancements in healthcare. This is a key aspect of its Viatris pharmaceutical marketing.

Patient Advocacy Partnerships

The company collaborates with patient organizations to raise awareness and improve access to treatments. These partnerships are vital for addressing patient needs and supporting community health initiatives.

Patient Assistance Programs

Viatris offers patient assistance programs, providing essential medicines free of charge to individuals with demonstrated financial need. This reflects a core element of its Viatris business strategy focused on accessibility.

Focus on Core Competencies and Unmet Needs

Viatris's marketing mix has evolved to concentrate on its core competencies, particularly in complex generics and novel products. The company actively seeks to add capabilities that address unmet medical needs, aligning with its overall Viatris sales strategy.

• Emphasis on scientific and medical education for healthcare professionals.
• Strategic regulatory engagement to facilitate market access.
• Direct communication channels with healthcare providers.
• Development of specialized programs for complex generics and novel products.
• Commitment to patient access through assistance programs and advocacy.

Viatris PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Viatris has established a distinct brand positioning as a global healthcare company dedicated to empowering individuals worldwide to lead healthier lives at every life stage. This positioning is built upon a strategy that bridges the gap between generic and branded pharmaceuticals, offering a comprehensive portfolio that includes both. This hybrid approach allows Viatris to combine the established reliability and affordability of generics with the innovation and patient-centric focus often associated with branded medicines, setting it apart in the market.

The company's core message, 'access at scale,' underscores its extensive global reach, serving over 165 countries and territories. This is supported by a sophisticated supply chain designed to ensure the consistent delivery of high-quality medicines where and when they are most needed. Viatris effectively communicates its value proposition to healthcare providers, patients, and health systems by emphasizing its commitment to delivering value, quality, and sustainable healthcare solutions.

Bridging Generics and Brands

Viatris differentiates itself by offering a diverse product range that includes branded, generic, and biosimilar medicines. This strategy aims to provide patients with a spectrum of choices, balancing cost-effectiveness with therapeutic innovation.

Global Access and Supply Chain Excellence

The brand's promise of 'access at scale' is a cornerstone of its identity, highlighting its presence in over 165 countries. A robust supply chain ensures that essential medicines reach patients reliably, reinforcing trust and accessibility.

Focus on Value and Innovation

Viatris appeals to its stakeholders by focusing on value-driven healthcare solutions. The company's investment in complex generics and novel products, with a 'first-to-market emphasis,' demonstrates its commitment to innovation within the off-patent sector.

Commitment to Biosimilars

The company is actively developing biosimilars, recognizing their significant potential to lower drug costs. Projections suggest that the broader adoption of biosimilars could reduce U.S. drug costs by as much as $100 billion over the next five years.

Viatris maintains brand consistency through its 'Global Healthcare Gateway,' a strategic initiative that leverages its extensive infrastructure to connect partners and patients across the globe. This approach reinforces its brand promise of reliability and broad access, even amidst operational challenges, such as the impact of the Indore manufacturing facility on Q1 2025 revenues. The company continues to emphasize its strong base business and pipeline advancements as key components of its enduring brand strategy.

Target Audience Appeal

Viatris targets healthcare providers, patients, and health systems by highlighting its commitment to value, quality, and sustainable healthcare solutions.

Innovation in Generics

The company's focus on complex generics and novel products, with a 'first-to-market emphasis,' showcases its innovative drive within the off-patent pharmaceutical segment.

Biosimilar Market Impact

Viatris's engagement with biosimilars is poised to significantly reduce drug costs, contributing to a projected $100 billion reduction in U.S. drug expenses over the next five years.

Global Connectivity

The 'Global Healthcare Gateway' facilitates international connections, reinforcing Viatris's brand as a reliable partner in global healthcare delivery.

Brand Promise Reinforcement

Despite market fluctuations, Viatris consistently reaffirms its commitment to its core business and pipeline, ensuring its brand promise of reliability and access remains strong.

Strategic Market Positioning

Viatris's brand positioning is fundamentally about empowering people worldwide to live healthier lives by providing accessible, high-quality medicines across diverse therapeutic areas.

Viatris Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Viatris's sales and marketing strategy is deeply intertwined with its overarching business objectives, focusing on market access, successful new product introductions, and robust education for healthcare professionals. A significant aspect of their current campaign involves a strategic pivot towards innovative and high-growth products, aiming to mitigate the inherent volatility associated with the generics market. This shift, which gained momentum in 2024, is characterized by a deliberate emphasis on highlighting revenues from new products.

In 2024, new product revenues reached $582 million, with projections for 2025 anticipated to fall between $450 million and $550 million. The company has outlined key product launches planned for 2025, including Iron Sucrose (Venofer®), Octreotide (Sandostatin® LAR), and Glucagon, each supported by comprehensive commercial execution plans designed to maximize market penetration. This approach reflects a dynamic Viatris sales strategy that adapts to evolving market demands.

New Product Revenue Focus

Viatris is actively promoting its new product portfolio, which generated $582 million in 2024. The company anticipates this segment to contribute between $450 million and $550 million in 2025, showcasing a clear Viatris business strategy centered on growth drivers.

Key 2025 Product Launches

Anticipated launches for 2025 include Iron Sucrose (Venofer®), Octreotide (Sandostatin® LAR), and Glucagon. These introductions are backed by detailed commercial plans to ensure effective market entry and adoption, a core element of the Viatris marketing strategy.

Recent Product Contributions

Specific product launches like Breyna™ and lisdexamfetamine in the U.S., along with Rivaroxaban in select European markets, significantly boosted new product revenues in 2024. These products collectively contributed approximately $133 million in Q3 2024 and $210 million in Q2 2024, demonstrating successful Viatris sales tactics.

Resilience in Launch Strategy

Despite a Complete Response Letter from the FDA in March 2024 for a long-acting glatiramer acetate injection, Viatris maintained its 2024 new product revenue guidance. This resilience highlights the effectiveness of their Viatris product launch marketing plan and overall sales approach.

Beyond product-specific marketing, Viatris actively engages in impactful global health initiatives that reinforce its brand mission and commitment to patient access. The NCD Academy, an online educational platform for healthcare workers, has seen substantial growth, reaching over 30,000 accounts and impacting approximately 115 million patients by 2024. Events like the 'Viatris Masterclass 2024', held in collaboration with Vietnamese medical associations, further exemplify their dedication to capability building and enhancing patient care through informed practices, showcasing Viatris's strategies for patient advocacy marketing.

NCD Academy Growth

The NCD Academy, a free online educational platform, has expanded significantly. By 2024, it boasted over 30,000 accounts and reached approximately 115 million patients globally.

Healthcare Professional Education

Viatris conducts initiatives like the 'Viatris Masterclass 2024' to elevate patient care. These events foster capability building and idea exchange among healthcare professionals.

Global Health Impact

These educational campaigns underscore Viatris's commitment to global health. They are integral to the company's broader Viatris marketing strategy and brand positioning.

Strategic Market Pivot

The company is strategically shifting its focus towards innovative and high-growth products. This move aims to reduce reliance on the generics market, a key aspect of their Viatris business strategy.

Product Launch Success

Successful launches of products like Breyna™ and lisdexamfetamine contributed significantly to 2024 revenues. This demonstrates effective Viatris sales and marketing plan execution.

Adapting to Challenges

Viatris maintained its new product revenue guidance despite regulatory feedback on a biosimilar candidate. This highlights their adaptive Viatris sales approach and robust market penetration strategies.

Viatris Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔